eGenesis

Restoring life after organ failure.

Cambridge, United States · Founded 2015 · $316.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$316.0M
Last Round
$191.0M Series DSep 2024
Rounds
4

About

eGenesis is a biotechnology company developing human-compatible organs using multiplexed gene editing and genome engineering. Focused on kidney, liver, and heart transplants via xenotransplantation from genetically modified pigs to end organ shortages and waitlists. Achieved FDA IND clearance for Phase 1/2/3 kidney trials.

Summary

eGenesis is a Biotech company based in Cambridge, United States, founded in 2015. It has raised $316.0M in total across 4 rounds, most recently a $191.0M Series D round in Sep 2024. Investors include Lux Capital, Fresenius Medical Care and Biomatics Capital Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series DSeries DSep 2024
$191.0M

Sign up to see all 4 rounds

Series A through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

eGenesis on Indexed.vc
<a href="https://indexed.vc/companies/egenesis"><img src="https://indexed.vc/api/badge/company/egenesis" alt="eGenesis on Indexed.vc" width="260" height="76" /></a>